Isaly Samuel D
SEC-identified person · CIK 1055949 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Xtant Medical Holdings, Inc. XTNT | Officer | filed 2018–2018 |
| Kala Pharmaceuticals, Inc. KALA | Officer | filed 2017–2018 |
| Pieris Pharmaceuticals, INC. PVLA | Director | filed 2015–2018 |
| Loxo Oncology, Inc. LOXO | Director | filed 2014–2017 |
| Scpharmaceuticals Inc. SCPH | Officer | filed 2017–2017 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017–2017 |
| Rhythm Pharmaceuticals, INC. SRYTM | Officer | filed 2017–2017 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014–2017 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016–2017 |
| Glaukos Corp GKOS | Director | filed 2015–2017 |
| Synlogic, INC. SYBX | Director | filed 2017–2017 |
| Nivalis Therapeutics, Inc. NVLS | Director | filed 2017–2017 |
| CTI Biopharma Corp ctic | Officer | filed 2017–2017 |
| Steadymed Ltd. STDY | Officer | filed 2016–2017 |
| Adaptimmune Therapeutics PLC ADAP] | Director | filed 2016–2017 |
| Zeta Acquisition Corp II WHWK | Director | filed 2017–2017 |
| Spyre Therapeutics, Inc. SYRE | Officer | filed 2016–2017 |
| Viewray, Inc. VRAY | Director | filed 2016–2017 |
| Nabriva Therapeutics plc NBRV | Director | filed 2016–2016 |
| Response Biomedical Corp RBM | Director | filed 2012–2016 |
| Relypsa Inc RLYP | Officer | filed 2013–2016 |
| Selecta Biosciences INC SELB | Director | filed 2016–2016 |
| Corvus Pharmaceuticals, Inc. CRVS | Director | filed 2016–2016 |
| Intellia Therapeutics, Inc. NTLA | Director | filed 2016–2016 |
| Otonomy, Inc. OTIC | Director | filed 2014–2015 |
| Dimension Therapeutics, Inc. DMTX | Director | filed 2015–2015 |
| Sientra, Inc. SIEN | Officer | filed 2014–2015 |
| Intercept Pharmaceuticals, INC. ICPT | Director | filed 2012–2015 |
| Sierra Oncology, Inc. SRRA | Director | filed 2015–2015 |
| Mirati Therapeutics, Inc. mrtx | Officer | filed 2013–2015 |
| Acceleron Pharma INC XLRN | Officer | filed 2013–2013 |
| Ambit Biosciences Corp AMBI | Officer | filed 2013–2013 |
| Supernus Pharmaceuticals, INC. SUPN | Director | filed 2012–2013 |
| Anthera Pharmaceuticals Inc ANTH | Director | filed 2010–2013 |
| Amarin Corp PLC\UK AMRN | Director | filed 2011–2012 |
| Complete Genomics INC GNOM | Officer | filed 2010–2012 |
| Pacira Pharmaceuticals, Inc. PCRX | Officer | filed 2011–2012 |
| Chemocentryx, Inc. CCXI | Officer | filed 2012–2012 |
| Bthc VI Inc NA | Director | filed 2008–2011 |
| Nxstage Medical, Inc. NXTM | Director | filed 2008–2010 |
| Kun Run Biotechnology, Inc. KURU.OB | Officer | filed 2010–2010 |
| Biodel Inc BIODEL | Director | filed 2008–2009 |
| Aryx Therapeutics, Inc. ARYX | Director | filed 2007–2009 |
| Cryocor INC CRYO | Officer | filed 2007–2007 |
| Insulet Corp PODD | Director | filed 2007–2007 |
| Volcano Corp VOLC | Director | filed 2006–2006 |
| Avanir Pharmaceuticals, INC. AVNR | Director | filed 2006–2006 |
| Given Imaging LTD GIVN | Director | filed 2006–2006 |
| DOV Pharmaceutical INC DVOP | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.